François Blondel is an accomplished executive with extensive experience in the biotechnology and life sciences sectors. Currently serving as CEO and Managing Director of KitoZyme since January 2013, François also holds the positions of Executive Chairman of the Board and Founder of KiOmed Pharma, which started in March 2014. As a co-founder, François has contributed to Biokuris since June 2021 and serves as Vice-Chairman of the Board for OncoDNA since December 2012. Additional roles include Director positions at Kazidomi, IntegraGen (an OncoDNA Group Company), and essenscia, along with advisory responsibilities at Kazidomi. François's leadership experience extends to previous roles as Chairman of the Board for Wishbone Biotech and Director at Sopartec sa, alongside former directorship at Union Wallonne des Entreprises.
Sign up to view 0 direct reports
Get started